Publikationen von 0000-0002-4462-3694
(ORCID: 0000-0002-4462-3694)

Hart, Christina, Klamroth, Robert, Sachs, Ulrich J., Greil, Richard , Knoebl, Paul N., Oldenburg, Johannes, Miesbach, Wolfgang, Pfrepper, Christian , Trautmann-Grill, Karolin, Pekrul, Isabell, Holstein, Katharina, Eichler, Hermann, Weigt, Carmen, Schipp, Dorothea, Werwitzke, Sonja und Tiede, Andreas (2023) Emicizumab Versus Immunosuppression for Acquired Hemophilia Α (AHA). Blood 142 (Supple), S. 2612.

Oleshko, Olga , Werwitzke, Sonja, Klingberg, Annika, Witte, Torsten, Eichler, Hermann, Klamroth, Robert, Holstein, Katharina, Hart, Christina, Pfrepper, Christian , Knöbl, Paul , Greil, Richard , Neumeister, Peter, Reipert, Birgit M. und Tiede, Andreas (2023) Targets of autoantibodies in acquired hemophilia A are not restricted to factor VIII: data from the GTH-AH 01/2010 study. Blood Advances 7 (1), S. 122-130. Volltext nicht vorhanden.

Behringer, Karolin, Goergen, Helen, Hitz, Felicitas, Zijlstra, Josée M, Greil, Richard , Markova, Jana, Sasse, Stephanie, Fuchs, Michael, Topp, Max S, Soekler, Martin, Mathas, Stephan, Meissner, Julia, Wilhelm, Martin, Koch, Peter, Lindemann, Hans-Walter, Schalk, Enrico, Semrau, Robert, Kriz, Jan, Vieler, Tom, Bentz, Martin, Lange, Elisabeth, Mahlberg, Rolf, Hassler, Andre, Vogelhuber, Martin, Hahn, Dennis, Mezger, Jörg, Krause, Stefan W , Skoetz, Nicole, Böll, Boris, von Tresckow, Bastian, Diehl, Volker, Hallek, Michael, Borchmann, Peter, Stein, Harald, Eich, Hans und Engert, Andreas (2015) Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial. The Lancet 385 (9976), S. 1418-1427. Volltext nicht vorhanden.

d'Amore, Francesco, Leppä, Sirpa, da Silva, Maria Gomes, Relander, Thomas, De Nully Brown, Peter, Weidmann, Eckhart, Lauritzsen, Grete Fossum, Pezzutto, Antonio, Van Hoof, Achiel, van Gelder, Michel, Doorduijn, Jeanette K, Wu, Ka Lung, Kluin-Nelemans, J.C., Lugtenburg, P.J., Jankovska, Milada, Merup, Mats, Fagerli, Unn-Merete, Walewski, Jan, Hagberg, Hans, Mariz, Jose Mario, Hansen, Per Boye, Nösslinger, Thomas, Janssens, Ann, Brandefors, Lena, Demuynck, Hilde, Schaafsma, Martyn Ronald, Christiansen, Ilse, Salek, David, Jyrkkiö, Sirkku, Prochazka, Vit, Zijlstra, Josee, Böhmer, L., Greil, Richard , Stevens, Wendy, Fijnheer, Rob, van Marwijk Kooy, Marinus, Grube, Matthias, Hopfinger, Georg, Van den Neste, Eric, Jantunen, Esa, Trümper, Lorenz, Wulf, Gerald, Altmann, Bettina, Ziepert, Marita, Loeffler, Markus und Toldbod, Helle (2012) First Interim Efficacy and Safety Analysis of an International Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with Chemotherapy with or without Alemtuzumab and Consolidated by High Dose Therapy. Blood 120 (21), S. 57. Volltext nicht vorhanden.

Engert, Andreas, Haverkamp, Heinz, Kobe, Carsten, Markova, Jana, Renner, Christoph, Ho, Antony, Zijlstra, Josée, Král, Zdenek, Fuchs, Michael, Hallek, Michael, Kanz, Lothar, Döhner, Hartmut, Dörken, Bernd, Engel, Nicole, Topp, Max, Klutmann, Susanne, Amthauer, Holger, Bockisch, Andreas, Kluge, Regine, Kratochwil, Clemens, Schober, Otmar, Greil, Richard , Andreesen, Reinhard, Kneba, Michael, Pfreundschuh, Michael, Stein, Harald, Eich, Hans Theodor, Müller, Rolf-Peter, Dietlein, Markus, Borchmann, Peter und Diehl, Volker (2012) Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial. The Lancet 379 (9828), S. 1791-1799. Volltext nicht vorhanden.

d'Amore, Francesco, da Silva, Maria Gomes, Leppa, Sirpa , Relander, Thomas, Pezzutto, Antonio, Lauritzsen, Grete F., Weidmann, Eckhart, Van Gelder, Michel, Merup, Mats, Hagberg, Hans, Fagerli, Unn-Merete, Brown, Peter de Nully, Hansen, Per Boye, Mariz, Jose Mario, Jankovska, Milada, Walewski, Jan, Doorduijn, Jeanette, Van Hoof, Achiel, Christiansen, Ilse, Jyrkkiö, Sirkku, Kluin-Nelemans, J.C., van Marwijk Kooy, Marinus, Fijnheer, Rob, Stevens, Wendy, Zijlstra, Josee, Böhmer, L., Lugtenburg, P.J., Grube, Matthias, Prochazka, Vit, Salek, David, Greil, Richard , Trümper, Lorenz, Wulf, Gerald, Altmann, Bettina, Ziepert, Marita, Loeffler, Markus, Jantunen, Esa, Hopfinger, Georg, Neste, Eric Van den und Toldbod, Helle (2011) First Interim Safety Analysis of a Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated by Autologous Hematopoietic Stem Cell Transplant,. Blood 118 (21), S. 4110. Volltext nicht vorhanden.

Gokbuget, N., Hartog, C.-M., Bassan, R., Derigs, H.-G., Dombret, H., Greil, R. , Hernandez-Rivas, J.-M. , Huguet, F., Intermesoli, T., Jourdan, E., Junghanss, C., Leimer, L., Moreno, M.-J., Reichle, A., Ribera, J., Schmid, M., Serve, H. , Stelljes, M., Stuhlmann, R. und Hoelzer, D. (2011) Liposomal cytarabine is effective and tolerable in the treatment of central nervous system relapse of acute lymphoblastic leukemia and very aggressive lymphoma. Haematologica 96 (2), S. 238-244. Volltext nicht vorhanden.